Roland Schluter

Title: Roland Schluter: Innovator in Implantable Active Ingredient Depots

Introduction

Roland Schluter is a notable inventor based in Soest, Germany. He has made significant contributions to the field of medicine and the pharmaceutical industry through his innovative work on implantable active ingredient depots. His inventions aim to improve therapeutic outcomes for patients, particularly in oncological therapy and gene therapy.

Latest Patents

Schluter holds a patent for an "Implantable Active Ingredient Depot." This invention relates to a depot designed for the controlled release of therapeutically active substances. The depot is composed of a lipid matrix capable of forming cubic phases, into which modifier molecules are integrated. A preferred lipid matrix used in this invention is monooleine. The design allows for precise control over the release of active ingredients, making it particularly useful in treating tumors and in gene therapy applications.

Career Highlights

Roland Schluter is associated with the Max-Delbrück-Centrum für Molekulare Medizin, where he continues to advance research in molecular medicine. His work has been instrumental in developing new therapeutic strategies that leverage the capabilities of implantable depots.

Collaborations

One of his notable collaborators is Regina Reszka, with whom he has worked on various projects related to his patent.

Conclusion

Roland Schluter's innovative contributions to the field of implantable active ingredient depots highlight his commitment to advancing medical therapies. His work continues to pave the way for new treatment options in oncology and gene therapy.